WINNER! KYMIRA are Awarded the Barclays Award for Innovation

Despite a globally tough year, KYMIRA’s been having one of our best ever years in 2020, and we’ve been committed to continuing to innovate, continuing research, continuing growth and continuing to change lives.

We’re thrilled to be recognised by Barclays for our efforts, and to announce that we’re the 2020 winners of the Eagle Labs Innovation Award for 2020! We were delighted to win in this category and an award for  regionally earlier this year, so to win the award on a national scale is something we’re especially proud of.

Of the win, our Founder and CEO Tim Brownstone said:

“I was speechless to have won the Barclays Entrepreneur Award as it is such a hotly contested and internationally recognised event. It means an awful lot to me to win the award as Barclays and the Eagle Labs network have supported us as a business for a number of years now, and we have always done our best to give back and support the wider network too.”

KYMIRA’s win was based on our innovations within the cardiac, internal movement and foetal monitoring research alongside the innovation of the K-Filter nanofibre filtration fabric that effectively filters 99.6%* of viral, pollutant and bacterial particles.

Jon Hope, Eagle Labs Director, said:

“We would like to congratulate KYMIRA for their win. The Barclays Entrepreneur Awards are a celebration of the exceptional innovation and leadership entrepreneurs show, driving job growth, attracting investment, and creating innovative products and services. For the Eagle Labs Innovation Award, the judges were looking for a company that had demonstrated impact through digital employment and innovative collaboration and KYMIRA exhibited these qualities through its great products, technology and teamwork.”

As ever, we’d like to thank our supporters, the KYMIRA Team and Barclays, for this recognition.

Click here to see Barclay’s announcement of the win, runners up and all the other great winners:

Stay up to date with our latest developments.